Search results
Results from the WOW.Com Content Network
Serial Experiments Lain is a Japanese anime television series created and co-produced by Yasuyuki Ueda, written by Chiaki J. Konaka and directed by Ryūtarō Nakamura. Animated by Triangle Staff and featuring original character designs by Yoshitoshi Abe, the series was broadcast for 13 episodes on TV Tokyo and its affiliates from July to ...
The game was designed as a "network simulator" which the player would navigate to explore Lain's journey between real life and online life. [1] The creators themselves did not describe it as a game but as "Psycho-Stretch-Ware," [1] incorporating visual novel and non-linear multimedia elements; the gameplay is limited to unlocking pieces of information and then reading/viewing/listening to them ...
Visual Experiments Lain; Essence (May, 2001) *Released in the US* NieA Under 7 - Scrap (July, 2001) Haibane Renmei - In the Town of Guri, in the Garden of Charcoal Feathers (December, 2003) yoshitoshi ABe lain illustrations - ab# rebuild an omnipresence in the wired (Japan: December 2005; US: April 2006) Gaisokyu (August, 2007) Manga
The search engine that helps you find exactly what you're looking for. Find the most relevant information, video, images, and answers from all across the Web.
Despera (ですぺら, Desupera) is a planned anime series, written by Chiaki J. Konaka and featuring character designs by Yoshitoshi Abe.It is Abe and Konaka's third collaboration, following Texhnolyze and Serial Experiments Lain.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Chiaki J. Konaka (小中 千昭, Konaka Chiaki, born April 4, 1961) is a Japanese writer and novelist. He was the head writer of anime series such as Serial Experiments Lain (1998), The Big O (1999-2003), Digimon Tamers (2001-02), Hellsing (2001-02), and Texhnolyze (2003), as well as the television drama Ultraman Tiga (1996-97).
The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx ...